Zosano Pharma (ZSAN) - Management Comments

Zosano Pharma (ZSAN) – Management Comments

Feb 22, 2021 08:32 AM Zosano Pharma (ZSAN) Receives Type A Meeting Minutes from FDA, Confirming NDA Resubmission Strategy
Feb 1, 2021 08:32 AM Zosano Pharma (ZSAN) Presents Early-Onset of Action Data for Qtrypta in Acute Treatment of Migraines
Feb 1, 2021 08:06 AM
Sep 30, 2020 05:41 PM
Aug 18, 2020 08:32 AM
Aug 7, 2020 06:26 AM
May 1, 2020 05:10 PM
Mar 4, 2020 08:02 AM
Dec 23, 2019 08:04 AM
Nov 13, 2019 04:30 PM
Oct 24, 2019 09:22 AM
Oct 8, 2019 09:05 AM
Sep 9, 2019 08:32 AM
Aug 14, 2019 09:01 AM
Jan 31, 2019 08:33 AM
Jan 16, 2019 08:31 AM
Dec 12, 2018 08:35 AM
Oct 16, 2018 08:31 AM
Jul 17, 2018 08:34 AM
Jun 20, 2018 08:50 AM
May 23, 2018 08:34 AM
May 22, 2018 08:30 AM
Nov 8, 2017 08:32 AM
Oct 12, 2017 02:45 PM
Oct 4, 2017 09:02 AM
Aug 28, 2017 08:32 AM
Jul 31, 2017 09:31 AM
Jun 26, 2017 08:35 AM
Jun 12, 2017 08:37 AM
Feb 13, 2017 08:40 AM
Nov 22, 2016 05:01 PM
Jun 17, 2016 08:33 AM
Jan 7, 2016 04:07 PM
Oct 13, 2015 08:38 AM
Sep 28, 2015 04:07 PM
Sep 8, 2015 04:45 PM
Sep 1, 2015 04:06 PM
Jul 13, 2015 08:35 AM
Jun 23, 2015 07:46 AM
Jan 28, 2015 06:08 PM